Alkem MedTech Pvt Ltd, a wholly-owned subsidiary of Alkem Laboratories, has announced the execution of a binding offer to acquire a majority stake of up to 55% in Occlutech Holding AG, a global leader in minimally invasive cardiac implants based in Switzerland. The transaction value is set at EUR 99.4 million (Approx. INR 1,074 crore). This move marks Alkem MedTech’s strategic entry into the advanced cardiovascular devices segment, leveraging Occlutech’s strong presence in Europe and the US.
Search
